Stockreport

Homology Medicines Advances First Gene Editing Development Candidate into IND-Enabling Studies for Pediatric Patients with Phenylketonuria

Homology Medicines, Inc.  (FIXX) 
Last homology medicines, inc. earnings: 3/12 04:10 pm Check Earnings Report
PDF - Data Demonstrates Highly Efficient and Selective In Vivo Gene Editing in a Humanized Murine Model - - New Internal GMP Manufacturing Capability to Support Gene Therap [Read more]